Tagged with M

Ireland Iwer Baecker, MD of Bayer Ireland, outlines the Irish affiliate’s impressive growth in the past few years, the strategy of New Bayer and how it comes into play in Ireland, as well as how Ireland’s small size is not a constraint but rather a huge opportunity to be taken advantage…

Mexico This chart gives an insight into the phenomenal importance of the pharmaceutical industry to Mexico, in terms of both monetary value and employment created. Public, private, and out of pocket healthcare coverage in Mexico. The growth of the Mexican pharma industry by patented, generic and OTC segments. API Manufacturing compared…

Mexico Due to economic necessity, the Mexican government is attempting to slash annual spending; an act that could have serious consequences on the country’s ability to provide its citizens with healthcare. Here, representatives of government, associations, social security institutions, and private companies impart their expertise on how best to navigate these…

Mexico Francisco Rodriguez, general manager Mexico and Latin America at Mundipharma, provides an overview of the customized market approach that has allowed the company to establish itself as the partner of choice of the medical and regulatory authorities in the pain management field, and how Mundipharma now looks at replicating similar…

Actelion Johnson & Jonhson’s interest in taking over the Swiss biotech group Actelion has been confirmed, with the Wall Street Journal estimating that a total takeover price could top USD 20 billion. As Actelion is a market leader in some therapeutic areas such as pulmonary arterial hypertension (PAH), the acquisition could…

Switzerland Developing manufacturing capacity for as yet unapproved drugs can create huge risk on innovators’ balance sheets, risk which can be mitigated by working instead with a competent CMO – a form of insurance as explained by Siegfried CEO Rudolf Hanko.   The CMO sector has grown faster than the pharma…

Philippines Alvin So, Bayer Consumer Health Country Division Head, discusses Bayer’s commitment in Consumer Health in the Philippines. He also discusses his vision for the future, including expanding the product portfolio in the country and continuing to be the partner of choice for the Filipino population. When you assumed the position…

Singapore In an exclusive interview with Richard Saynor at GSK, he outlines the growth of the CEP portfolio in emerging markets and highlights the opportunities and challenges in the region, as well as the strategic benefits of operating in Singapore.   Even though our key medicines have many generic competitors, their…

Mexico Jorge Romero Castañeda and María Eugenia Mendez, Healthcare & Life Science leader and Strategy & Operations Director at Deloitte respectively, share their expertise about the Healthcare & Life Science sector in Mexico and showcase the integral solutions that the firm offers to the industry to help companies gain competitiveness as…

Switzerland Specializing in ultra-rare diseases, Alexion targets patient populations of less than 20 patients per million. Christophe Bourdon discusses Alexion’s progress towards developing access for patients across the EMEA region.   Since day one, Alexion’s mission has been to focus solely on discovering treatments for patients affected by these incredibly rare…

Mexico Leonardo Torres, general manager Mexico, Central America & Caribbean of Shire, provides insights into the rapidly progressing integration of Baxalta in Mexico, while he also highlights his key priorities to further accelerate the growth and consolidate the strategic positioning of Shire, a company that now proudly stands out as the…

Luxembourg In an exclusive interview, Romain Schneider, Minister of Social Security for Luxembourg, on the successes of the Luxembourgish social security system, areas for improvement, and Luxembourg’s positioning within Europe. You were appointed Minister of Social Security nearly three years ago now, in December 2013. What have been the main changes…